Rugo HS, Campbell M, Yau C, Jo Chien A, et al. Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer. Breast Cancer Res Treat 2024 Dec 3. doi: 10.1007/s10549-024-07555.
PMID: 39625569